| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 232 |
| 1 | ADALIMUMAB | 229 |
| 2 | INFLIXIMAB | 218 |
| 3 | LEFLUNOMIDE | 218 |
| 4 | METHOTREXATE | 218 |
| 5 | ETANERCEPT | 217 |
| 6 | SULFASALAZINE | 211 |
| 7 | RITUXIMAB | 210 |
| 8 | TOCILIZUMAB | 207 |
| 9 | ABATACEPT | 204 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0714 |
| 1 | FEBUXOSTAT TABLETS 40 MG | 115 | 0.0117 |
| 2 | DIMENHYDRINATE | 114 | 0.0110 |
| 3 | TETRACAINE HYDROCHLORIDE | 1 | 0.0083 |
| 4 | GOLD | 46 | 0.0081 |
| 5 | FEBUXOSTAT | 128 | 0.0078 |
| 6 | COLCHICINE | 127 | 0.0050 |
| 7 | AMMONIUM CHLORIDE | 1 | 0.0045 |
| 8 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 90 | 0.0039 |
| 9 | ADALIMUMAB-FKJP | 166 | 0.0038 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 235 |
| 1 | Antirheumatic Agent [EPC] | 218 |
| 2 | Folate Analog Metabolic Inhibitor [EPC] | 218 |
| 3 | Aminosalicylate [EPC] | 211 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 210 |
| 5 | Interleukin-6 Receptor Antagonist [EPC] | 208 |
| 6 | Selective T Cell Costimulation Modulator [EPC] | 204 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 169 |
| 8 | Corticosteroid [EPC] | 159 |
| 9 | Vitamin B12 [EPC] | 145 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Alkaloid [EPC] | 127 | 0.0049 |
| 1 | Antirheumatic Agent [EPC] | 218 | 0.0021 |
| 2 | Aminosalicylate [EPC] | 211 | 0.0016 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 208 | 0.0016 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 204 | 0.0015 |
| 5 | Interleukin-12 Antagonist [EPC] | 126 | 0.0013 |
| 6 | Phosphodiesterase 4 Inhibitor [EPC] | 129 | 0.0008 |
| 7 | Xanthine Oxidase Inhibitor [EPC] | 128 | 0.0008 |
| 8 | Interleukin-17A Antagonist [EPC] | 116 | 0.0006 |
| 9 | Interleukin-23 Antagonist [EPC] | 126 | 0.0006 |